Larson Financial Group LLC Has $132,000 Position in Maximus, Inc. (NYSE:MMS)

Larson Financial Group LLC reduced its holdings in shares of Maximus, Inc. (NYSE:MMS) by 12.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,575 shares of the health services provider’s stock after selling 214 shares during the period. Larson Financial Group LLC’s holdings in Maximus were worth $132,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Rise Advisors LLC boosted its position in Maximus by 1,445.0% in the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock valued at $26,000 after buying an additional 289 shares in the last quarter. VisionPoint Advisory Group LLC boosted its position in Maximus by 61.4% in the third quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock valued at $28,000 after buying an additional 145 shares in the last quarter. Anchor Investment Management LLC acquired a new position in Maximus in the fourth quarter valued at about $32,000. Kapitalo Investimentos Ltda acquired a new position in Maximus in the fourth quarter valued at about $52,000. Finally, Planned Solutions Inc. acquired a new position in Maximus in the fourth quarter valued at about $59,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Price Performance

NYSE:MMS traded up $1.23 on Wednesday, reaching $85.31. The stock had a trading volume of 566,279 shares, compared to its average volume of 334,857. The company has a market capitalization of $5.19 billion, a P/E ratio of 22.27 and a beta of 0.75. Maximus, Inc. has a 1-year low of $72.39 and a 1-year high of $90.65. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.63. The stock has a fifty day moving average price of $85.72 and a 200-day moving average price of $83.33.

Maximus (NYSE:MMS) last announced its earnings results on Wednesday, May 8th. The health services provider reported $1.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.31 by $0.26. Maximus had a net margin of 4.58% and a return on equity of 18.02%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the business earned $0.80 earnings per share. Maximus’s quarterly revenue was up 11.7% on a year-over-year basis. Research analysts forecast that Maximus, Inc. will post 5.79 EPS for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Saturday, August 31st. Stockholders of record on Thursday, August 15th will be given a dividend of $0.30 per share. The ex-dividend date is Thursday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.41%. Maximus’s payout ratio is 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.